Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL vs EMTRICITABINE\TENOFOVIR ALAFENAMIDE: Safety Overview

Metric EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL EMTRICITABINE\TENOFOVIR ALAFENAMIDE
Total FAERS Reports 7,225 2,973
Deaths Reported 141 245
Death Rate 2.0% 8.2%
Hospitalizations 535 452
Average Patient Age 46.5 yrs 46.4 yrs
% Female Patients 30.3% 21.9%